ruboxistaurin has been researched along with Weight Gain in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brugnoli, A; Ferroni, L; Gardin, C; Ioannidi, E; Longo, F; Morari, M; Morganti, C; Nigro, F; Pavan, C; Pinton, P; Rimessi, A; Vindigni, V; Zavan, B | 1 |
Aiello, LP; Clermont, A; Della Vecchia, K; King, GL; Kondo, T; Mastumoto, M; Rask-Madsen, C; Sotiropoulos, KB; Takahashi, J; Yasuda, Y | 1 |
2 other study(ies) available for ruboxistaurin and Weight Gain
Article | Year |
---|---|
Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotic-Induced Weight Gain.
Topics: Animals; Antipsychotic Agents; Cells, Cultured; Clozapine; Drug Delivery Systems; Enzyme Inhibitors; Indoles; Male; Maleimides; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Kinase C beta; Time Factors; Weight Gain | 2017 |
Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on edema and weight gain.
Topics: Adipose Tissue; Animals; Capillary Permeability; Diabetes Mellitus; Edema; Enzyme Activation; Enzyme Inhibitors; Hypoglycemic Agents; Indoles; Male; Maleimides; Mice; Mice, Knockout; Obesity; PPAR gamma; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Zucker; Receptor, Insulin; Rosiglitazone; Thiazolidinediones; Vascular Endothelial Growth Factor A; Weight Gain | 2006 |